Clinical classification in pediatric pulmonary arterial hypertension associated with congenital heart disease.

Human genome meeting 2016 : Houston, TX, USA. 28 February - 2 March 2016.

Predicting Peak Oxygen Uptake From the 6-Minute Walk Test in Patients With Pulmonary Hypertension.

Growth in children with pulmonary arterial hypertension: a longitudinal retrospective multiregistry study.

Using Registries to Understand Clinical Practice: A Lesson for Rare Disease.

Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension.

BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.

FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion.

Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.

Pulmonary hypertension in chronic lung disease of infancy.

Balloon atrial septostomy in pulmonary arterial hypertension: effect on survival and associated outcomes.

Extracorporeal membrane oxygenation with subclavian artery cannulation in awake patients with pulmonary hypertension.

[Pediatric pulmonary hypertension].

Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report.